- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02997228
Combinatiechemotherapie, Bevacizumab en/of Atezolizumab bij de behandeling van patiënten met deficiënte DNA-mismatchreparatie Gemetastaseerde colorectale kanker, de COMMIT-studie
Colorectale kanker Gemetastaseerde dMMR/MSI-H Immunotherapie (COMMIT)-studie: een gerandomiseerde fase III-studie van mFOLFOX6/Bevacizumab/Atezolizumab-combinatie versus monotherapie atezolizumab bij de eerstelijnsbehandeling van patiënten met deficiënte DNA-mismatch-reparatie (dMMR)/microsatelliet Instability-High (MSI-H) gemetastaseerde colorectale kanker
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of the tumor. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Studie Overzicht
Toestand
Interventie / Behandeling
- Ander: Quality-of-Life Assessment
- Biologisch: Bevacizumab
- Geneesmiddel: Fluorouracil
- Procedure: Magnetic Resonance Imaging
- Ander: Questionnaire Administration
- Procedure: Biospecimen Collection
- Geneesmiddel: Atezolizumab
- Geneesmiddel: Oxaliplatin
- Procedure: Computed Tomography
- Geneesmiddel: Leucovorin
- Procedure: Positron Emission Tomography
Gedetailleerde beschrijving
PRIMARY OBJECTIVE:
I. To determine the efficacy, based on progression-free survival (PFS), of fluorouracil, oxaliplatin, and leucovorin calcium (modified [m]FOLFOX6)/bevacizumab plus atezolizumab (combination) as compared to single agent atezolizumab.
SECONDARY OBJECTIVES:
I. To compare the overall survival. II. To compare the objective response rates (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
III. To determine the safety profiles of single agent atezolizumab and the combination of mFOLFOX6/bevacizumab/atezolizumab in patients with mismatch-repair deficient (dMMR)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC).
IV. To determine the duration of response. V. To determine the duration of stable disease. VI. To determine the rate of progression-free survival (PFS) at 12 months. VII. To evaluate the disease control rate (complete response [CR] + partial response [PR] + stable disease [SD]) at 12 months.
TRANSLATIONAL OBJECTIVE:
I. To bank tissue and blood samples for other future correlative studies from patients enrolled on the study.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I (CLOSED TO ACCRUAL 6/4/2020): Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) with or without positron emission tomography (PET) or magnetic resonance imaging (MRI) throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.
ARM II: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.
ARM III: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.
After completion of study treatment, patients are followed up every 8 weeks for 18 months, and then every 12 weeks for up to 5 years.
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studie Locaties
-
-
Arizona
-
Kingman, Arizona, Verenigde Staten, 86401
- Kingman Regional Medical Center
-
-
Arkansas
-
Jonesboro, Arkansas, Verenigde Staten, 72401
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
-
-
California
-
Anaheim, California, Verenigde Staten, 92806
- Kaiser Permanente-Anaheim
-
Baldwin Park, California, Verenigde Staten, 91706
- Kaiser Permanente-Baldwin Park
-
Bellflower, California, Verenigde Staten, 90706
- Kaiser Permanente-Bellflower
-
Berkeley, California, Verenigde Staten, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Concord, California, Verenigde Staten, 94520
- John Muir Medical Center-Concord
-
Fontana, California, Verenigde Staten, 92335
- Kaiser Permanente-Fontana
-
Harbor City, California, Verenigde Staten, 90710
- Kaiser Permanente South Bay
-
Irvine, California, Verenigde Staten, 92618
- Kaiser Permanente-Irvine
-
Los Angeles, California, Verenigde Staten, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Verenigde Staten, 90034
- Kaiser Permanente West Los Angeles
-
Marysville, California, Verenigde Staten, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Verenigde Staten, 95355
- Memorial Medical Center
-
Ontario, California, Verenigde Staten, 91761
- Kaiser Permanente-Ontario
-
Orange, California, Verenigde Staten, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, Verenigde Staten, 92868
- Saint Joseph Hospital - Orange
-
Panorama City, California, Verenigde Staten, 91402
- Kaiser Permanente - Panorama City
-
Riverside, California, Verenigde Staten, 92505
- Kaiser Permanente-Riverside
-
Sacramento, California, Verenigde Staten, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Verenigde Staten, 95817
- University of California Davis Comprehensive Cancer Center
-
Salinas, California, Verenigde Staten, 93901
- Salinas Valley Memorial
-
San Diego, California, Verenigde Staten, 92120
- Kaiser Permanente-San Diego Zion
-
San Diego, California, Verenigde Staten, 92108
- Kaiser Permanente-Rio San Diego
-
San Marcos, California, Verenigde Staten, 92078
- Kaiser Permanente-San Marcos
-
Walnut Creek, California, Verenigde Staten, 94598
- John Muir Medical Center-Walnut Creek
-
Whittier, California, Verenigde Staten, 90602
- Presbyterian Intercommunity Hospital
-
Woodland Hills, California, Verenigde Staten, 91367
- Kaiser Permanente-Woodland Hills
-
-
Colorado
-
Aurora, Colorado, Verenigde Staten, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, Verenigde Staten, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, Verenigde Staten, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Verenigde Staten, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, Verenigde Staten, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Verenigde Staten, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, Verenigde Staten, 80920
- Memorial Hospital North
-
Denver, Colorado, Verenigde Staten, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Verenigde Staten, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Verenigde Staten, 80204
- Denver Health Medical Center
-
Denver, Colorado, Verenigde Staten, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Verenigde Staten, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Verenigde Staten, 80210
- AdventHealth Porter
-
Englewood, Colorado, Verenigde Staten, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Verenigde Staten, 80113
- Swedish Medical Center
-
Fort Collins, Colorado, Verenigde Staten, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Verenigde Staten, 80528
- Cancer Care and Hematology-Fort Collins
-
Golden, Colorado, Verenigde Staten, 80401
- National Jewish Health-Western Hematology Oncology
-
Greeley, Colorado, Verenigde Staten, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, Verenigde Staten, 80631
- Banner North Colorado Medical Center
-
Littleton, Colorado, Verenigde Staten, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Verenigde Staten, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland, Colorado, Verenigde Staten, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, Verenigde Staten, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton, Colorado, Verenigde Staten, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Verenigde Staten, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Danbury, Connecticut, Verenigde Staten, 06810
- Danbury Hospital
-
Hartford, Connecticut, Verenigde Staten, 06102
- Hartford Hospital
-
Meriden, Connecticut, Verenigde Staten, 06451
- Midstate Medical Center
-
New Britain, Connecticut, Verenigde Staten, 06050
- The Hospital of Central Connecticut
-
Norwich, Connecticut, Verenigde Staten, 06360
- William Backus Hospital
-
-
Delaware
-
Millville, Delaware, Verenigde Staten, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, Verenigde Staten, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Verenigde Staten, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, Verenigde Staten, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, Verenigde Staten, 20002
- Kaiser Permanente-Capitol Hill Medical Center
-
-
Florida
-
Fort Lauderdale, Florida, Verenigde Staten, 33316
- Broward Health Medical Center
-
Fort Myers, Florida, Verenigde Staten, 33905
- Regional Cancer Center-Lee Memorial Health System
-
Gainesville, Florida, Verenigde Staten, 32610
- UF Health Cancer Institute - Gainesville
-
Jacksonville, Florida, Verenigde Staten, 32207
- Baptist MD Anderson Cancer Center
-
Orlando, Florida, Verenigde Staten, 32803
- AdventHealth Orlando
-
-
Georgia
-
Albany, Georgia, Verenigde Staten, 31701
- Phoebe Putney Memorial Hospital
-
Athens, Georgia, Verenigde Staten, 30607
- University Cancer and Blood Center LLC
-
Augusta, Georgia, Verenigde Staten, 30912
- Augusta University Medical Center
-
Augusta, Georgia, Verenigde Staten, 30901
- Augusta Oncology Associates PC-D'Antignac
-
Augusta, Georgia, Verenigde Staten, 30909
- Augusta Oncology Associates PC-Wheeler
-
Newnan, Georgia, Verenigde Staten, 30265
- CTCA at Southeastern Regional Medical Center
-
-
Idaho
-
Boise, Idaho, Verenigde Staten, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Verenigde Staten, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Verenigde Staten, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Verenigde Staten, 83814
- Kootenai Health - Coeur d'Alene
-
Fruitland, Idaho, Verenigde Staten, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Verenigde Staten, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Verenigde Staten, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Verenigde Staten, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Verenigde Staten, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Verenigde Staten, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Verenigde Staten, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington, Illinois, Verenigde Staten, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Verenigde Staten, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Verenigde Staten, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Verenigde Staten, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Verenigde Staten, 60612
- University of Illinois
-
Chicago, Illinois, Verenigde Staten, 60612
- Rush MD Anderson Cancer Center
-
Danville, Illinois, Verenigde Staten, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Verenigde Staten, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Verenigde Staten, 61021
- Illinois CancerCare-Dixon
-
Effingham, Illinois, Verenigde Staten, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Verenigde Staten, 62401
- Carle Physician Group-Effingham
-
Eureka, Illinois, Verenigde Staten, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, Verenigde Staten, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, Verenigde Staten, 61401
- Illinois CancerCare-Galesburg
-
Glenview, Illinois, Verenigde Staten, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Highland Park, Illinois, Verenigde Staten, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Kewanee, Illinois, Verenigde Staten, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Verenigde Staten, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Verenigde Staten, 61938
- Carle Physician Group-Mattoon/Charleston
-
Maywood, Illinois, Verenigde Staten, 60153
- Loyola University Medical Center
-
Mount Vernon, Illinois, Verenigde Staten, 62864
- SSM Health Good Samaritan
-
O'Fallon, Illinois, Verenigde Staten, 62269
- Cancer Care Center of O'Fallon
-
Ottawa, Illinois, Verenigde Staten, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Verenigde Staten, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Verenigde Staten, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Verenigde Staten, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Verenigde Staten, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Verenigde Staten, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Verenigde Staten, 62702
- Springfield Clinic
-
Urbana, Illinois, Verenigde Staten, 61801
- Carle Cancer Center
-
Washington, Illinois, Verenigde Staten, 61571
- Illinois CancerCare - Washington
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46237
- Franciscan Health Indianapolis
-
Indianapolis, Indiana, Verenigde Staten, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Verenigde Staten, 46219
- Community Cancer Center East
-
Indianapolis, Indiana, Verenigde Staten, 46227
- Community Cancer Center South
-
Indianapolis, Indiana, Verenigde Staten, 46256
- Community Cancer Center North
-
Kokomo, Indiana, Verenigde Staten, 46904
- Community Howard Regional Health
-
Lafayette, Indiana, Verenigde Staten, 47905
- Franciscan Saint Elizabeth Health - Lafayette East
-
Michigan City, Indiana, Verenigde Staten, 46360
- Woodland Cancer Care Center
-
Mooresville, Indiana, Verenigde Staten, 46158
- Franciscan Health Mooresville
-
Terre Haute, Indiana, Verenigde Staten, 47804
- Union Hospital
-
-
Iowa
-
Ames, Iowa, Verenigde Staten, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Verenigde Staten, 50010
- McFarland Clinic - Ames
-
Bettendorf, Iowa, Verenigde Staten, 52722
- University of Iowa Healthcare Cancer Services Quad Cities
-
Boone, Iowa, Verenigde Staten, 50036
- McFarland Clinic - Boone
-
Cedar Rapids, Iowa, Verenigde Staten, 52403
- Mercy Hospital
-
Cedar Rapids, Iowa, Verenigde Staten, 52403
- Oncology Associates at Mercy Medical Center
-
Clive, Iowa, Verenigde Staten, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Verenigde Staten, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Des Moines, Iowa, Verenigde Staten, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Verenigde Staten, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Verenigde Staten, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Verenigde Staten, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, Verenigde Staten, 50501
- McFarland Clinic - Trinity Cancer Center
-
Fort Dodge, Iowa, Verenigde Staten, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, Verenigde Staten, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Jefferson, Iowa, Verenigde Staten, 50129
- McFarland Clinic - Jefferson
-
Marshalltown, Iowa, Verenigde Staten, 50158
- McFarland Clinic - Marshalltown
-
West Des Moines, Iowa, Verenigde Staten, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Hays, Kansas, Verenigde Staten, 67601
- HaysMed
-
Lawrence, Kansas, Verenigde Staten, 66044
- Lawrence Memorial Hospital
-
Olathe, Kansas, Verenigde Staten, 66061
- The University of Kansas Cancer Center - Olathe
-
Salina, Kansas, Verenigde Staten, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Verenigde Staten, 66606
- University of Kansas Health System Saint Francis Campus
-
Westwood, Kansas, Verenigde Staten, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
Wichita, Kansas, Verenigde Staten, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Verenigde Staten, 67214
- Cancer Center of Kansas - Wichita
-
-
Kentucky
-
Bardstown, Kentucky, Verenigde Staten, 40004
- CommonSpirit Saint Joseph Hospital - Bardstown
-
Lexington, Kentucky, Verenigde Staten, 40536
- University of Kentucky/Markey Cancer Center
-
Lexington, Kentucky, Verenigde Staten, 40503
- Baptist Health Lexington
-
Lexington, Kentucky, Verenigde Staten, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Louisville, Kentucky, Verenigde Staten, 40202
- Norton Hospital Pavilion and Medical Campus
-
Louisville, Kentucky, Verenigde Staten, 40241
- Norton Brownsboro Hospital and Medical Campus
-
Louisville, Kentucky, Verenigde Staten, 40217
- Norton Audubon Hospital and Medical Campus
-
-
Louisiana
-
Kenner, Louisiana, Verenigde Staten, 70065
- Ochsner Medical Center Kenner
-
New Orleans, Louisiana, Verenigde Staten, 70121
- Ochsner Medical Center Jefferson
-
-
Maine
-
Augusta, Maine, Verenigde Staten, 04330
- Harold Alfond Center for Cancer Care
-
Bangor, Maine, Verenigde Staten, 04401
- Eastern Maine Medical Center
-
Belfast, Maine, Verenigde Staten, 04915
- MaineHealth Waldo Hospital
-
Biddeford, Maine, Verenigde Staten, 04005
- MaineHealth Maine Medical Center - Biddeford
-
Brewer, Maine, Verenigde Staten, 04412
- Lafayette Family Cancer Center-EMMC
-
Rockport, Maine, Verenigde Staten, 04856
- Penobscot Bay Medical Center
-
Sanford, Maine, Verenigde Staten, 04073
- MaineHealth Cancer Care and IV Therapy - Sanford
-
South Portland, Maine, Verenigde Staten, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21244
- Kaiser Permanente-Woodlawn Medical Center
-
Easton, Maryland, Verenigde Staten, 21601
- University of Maryland Shore Medical Center at Easton
-
Gaithersburg, Maryland, Verenigde Staten, 20879
- Kaiser Permanente-Gaithersburg Medical Center
-
Largo, Maryland, Verenigde Staten, 20774
- Kaiser Permanente - Largo Medical Center
-
Lutherville, Maryland, Verenigde Staten, 21093
- Kaiser Permanente Lutherville - Timonium Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02215
- Dana-Farber Cancer Institute
-
Lowell, Massachusetts, Verenigde Staten, 01854
- Lowell General Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Verenigde Staten, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Bay City, Michigan, Verenigde Staten, 48706
- McLaren Cancer Institute-Bay City
-
Bloomfield, Michigan, Verenigde Staten, 48302
- McLaren Cancer Institute-Bloomfield
-
Brighton, Michigan, Verenigde Staten, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Verenigde Staten, 48114
- Trinity Health Medical Center - Brighton
-
Brownstown, Michigan, Verenigde Staten, 48183
- Henry Ford Cancer Institute-Downriver
-
Canton, Michigan, Verenigde Staten, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Verenigde Staten, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Verenigde Staten, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Verenigde Staten, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Verenigde Staten, 48346
- McLaren Cancer Institute-Clarkston
-
Clarkston, Michigan, Verenigde Staten, 48346
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, Verenigde Staten, 48346
- Newland Medical Associates-Clarkston
-
Clinton Township, Michigan, Verenigde Staten, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn, Michigan, Verenigde Staten, 48126
- Henry Ford Medical Center-Fairlane
-
Detroit, Michigan, Verenigde Staten, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Verenigde Staten, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Verenigde Staten, 48334
- Weisberg Cancer Treatment Center
-
Flint, Michigan, Verenigde Staten, 48532
- McLaren Cancer Institute-Flint
-
Flint, Michigan, Verenigde Staten, 48532
- Singh and Arora Hematology Oncology PC
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Jackson, Michigan, Verenigde Staten, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- West Michigan Cancer Center
-
Lansing, Michigan, Verenigde Staten, 48910
- Karmanos Cancer Institute at McLaren Greater Lansing
-
Lansing, Michigan, Verenigde Staten, 48912
- University of Michigan Health - Sparrow Lansing
-
Lapeer, Michigan, Verenigde Staten, 48446
- McLaren Cancer Institute-Lapeer Region
-
Livonia, Michigan, Verenigde Staten, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Livonia, Michigan, Verenigde Staten, 48154
- Hope Cancer Clinic
-
Mount Clemens, Michigan, Verenigde Staten, 48043
- McLaren Cancer Institute-Macomb
-
Mount Pleasant, Michigan, Verenigde Staten, 48858
- McLaren Cancer Institute-Central Michigan
-
Novi, Michigan, Verenigde Staten, 48377
- Henry Ford Medical Center-Columbus
-
Petoskey, Michigan, Verenigde Staten, 49770
- McLaren Cancer Institute-Northern Michigan
-
Pontiac, Michigan, Verenigde Staten, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Verenigde Staten, 48341
- Trinity Health IHA Medical Group-Alice Gustafson Center
-
Port Huron, Michigan, Verenigde Staten, 48060
- McLaren-Port Huron
-
Saginaw, Michigan, Verenigde Staten, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Verenigde Staten, 48601
- MyMichigan Medical Center Saginaw
-
Tawas City, Michigan, Verenigde Staten, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Verenigde Staten, 49684
- Munson Medical Center
-
West Bloomfield, Michigan, Verenigde Staten, 48322
- Henry Ford West Bloomfield Hospital
-
West Branch, Michigan, Verenigde Staten, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Ypsilanti, Michigan, Verenigde Staten, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Bemidji, Minnesota, Verenigde Staten, 56601
- Sanford Joe Lueken Cancer Center
-
Burnsville, Minnesota, Verenigde Staten, 55337
- Minnesota Oncology - Burnsville
-
Deer River, Minnesota, Verenigde Staten, 56636
- Essentia Health - Deer River Clinic
-
Duluth, Minnesota, Verenigde Staten, 55805
- Essentia Health Cancer Center
-
Hibbing, Minnesota, Verenigde Staten, 55746
- Essentia Health Hibbing Clinic
-
Maplewood, Minnesota, Verenigde Staten, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Verenigde Staten, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Verenigde Staten, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Verenigde Staten, 55454
- Health Partners Inc
-
Saint Paul, Minnesota, Verenigde Staten, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Verenigde Staten, 55102
- United Hospital
-
Sandstone, Minnesota, Verenigde Staten, 55072
- Essentia Health Sandstone
-
Virginia, Minnesota, Verenigde Staten, 55792
- Essentia Health Virginia Clinic
-
-
Mississippi
-
Grenada, Mississippi, Verenigde Staten, 38901
- Baptist Cancer Center-Grenada
-
New Albany, Mississippi, Verenigde Staten, 38652
- Baptist Memorial Hospital and Cancer Center-Union County
-
Oxford, Mississippi, Verenigde Staten, 38655
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Southhaven, Mississippi, Verenigde Staten, 38671
- Baptist Memorial Hospital and Cancer Center-Desoto
-
-
Missouri
-
Ballwin, Missouri, Verenigde Staten, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Cape Girardeau, Missouri, Verenigde Staten, 63703
- Saint Francis Medical Center
-
Columbia, Missouri, Verenigde Staten, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Joplin, Missouri, Verenigde Staten, 64804
- Freeman Health System
-
Joplin, Missouri, Verenigde Staten, 64804
- Mercy Hospital Joplin
-
Kansas City, Missouri, Verenigde Staten, 64108
- University Health Truman Medical Center
-
St Louis, Missouri, Verenigde Staten, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Verenigde Staten, 63141
- Mercy Hospital Saint Louis
-
-
Montana
-
Anaconda, Montana, Verenigde Staten, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Verenigde Staten, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, Verenigde Staten, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Verenigde Staten, 59405
- Great Falls Clinic
-
Great Falls, Montana, Verenigde Staten, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, Verenigde Staten, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Verenigde Staten, 59901
- Logan Health Medical Center
-
Missoula, Montana, Verenigde Staten, 59804
- Community Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Verenigde Staten, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Verenigde Staten, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Verenigde Staten, 89183
- OptumCare Cancer Care at Fort Apache
-
Reno, Nevada, Verenigde Staten, 89502
- Renown Regional Medical Center
-
-
New Hampshire
-
Lebanon, New Hampshire, Verenigde Staten, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, Verenigde Staten, 03104
- Dartmouth Cancer Center - Manchester/ DCC Manchester
-
Nashua, New Hampshire, Verenigde Staten, 03063
- Dartmouth Cancer Center - Nashua
-
-
New Jersey
-
Hamilton, New Jersey, Verenigde Staten, 08690
- The Cancer Institute of New Jersey Hamilton
-
Morristown, New Jersey, Verenigde Staten, 07960
- Morristown Medical Center
-
New Brunswick, New Jersey, Verenigde Staten, 08903
- Rutgers Cancer Institute of New Jersey
-
Paramus, New Jersey, Verenigde Staten, 07652
- The Valley Hospital - Luckow Pavilion
-
Ridgewood, New Jersey, Verenigde Staten, 07450
- Valley Health System Ridgewood Campus
-
Somerville, New Jersey, Verenigde Staten, 08876
- Robert Wood Johnson University Hospital Somerset
-
Summit, New Jersey, Verenigde Staten, 07902
- Overlook Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Verenigde Staten, 87110
- Presbyterian Kaseman Hospital
-
Las Cruces, New Mexico, Verenigde Staten, 88011
- Memorial Medical Center-Las Cruces
-
Rio Rancho, New Mexico, Verenigde Staten, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Buffalo, New York, Verenigde Staten, 14263
- Roswell Park Cancer Institute
-
Elmira, New York, Verenigde Staten, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Lake Success, New York, Verenigde Staten, 11042
- Northwell Health/Center for Advanced Medicine
-
New York, New York, Verenigde Staten, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Verenigde Staten, 14642
- University of Rochester
-
White Plains, New York, Verenigde Staten, 10601
- Dickstein Cancer Treatment Center
-
-
North Carolina
-
Chapel Hill, North Carolina, Verenigde Staten, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Clinton, North Carolina, Verenigde Staten, 28328
- Southeastern Medical Oncology Center-Clinton
-
Goldsboro, North Carolina, Verenigde Staten, 27534
- Southeastern Medical Oncology Center-Goldsboro
-
Hendersonville, North Carolina, Verenigde Staten, 28791
- Margaret R Pardee Memorial Hospital
-
Jacksonville, North Carolina, Verenigde Staten, 28546
- Southeastern Medical Oncology Center-Jacksonville
-
Kenansville, North Carolina, Verenigde Staten, 28349
- ECU Health Oncology Kenansville
-
Kinston, North Carolina, Verenigde Staten, 28501
- ECU Health Oncology Kinston
-
Pinehurst, North Carolina, Verenigde Staten, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Richlands, North Carolina, Verenigde Staten, 28574
- ECU Health Oncology Richlands
-
Winston-Salem, North Carolina, Verenigde Staten, 27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck, North Dakota, Verenigde Staten, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Verenigde Staten, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Verenigde Staten, 58122
- Sanford Broadway Medical Center
-
Grand Forks, North Dakota, Verenigde Staten, 58201
- Altru Cancer Center
-
-
Ohio
-
Akron, Ohio, Verenigde Staten, 44307
- Cleveland Clinic Akron General
-
Belpre, Ohio, Verenigde Staten, 45714
- Strecker Cancer Center-Belpre
-
Centerville, Ohio, Verenigde Staten, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Verenigde Staten, 45459
- Dayton Physicians LLC-Miami Valley South
-
Chillicothe, Ohio, Verenigde Staten, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Verenigde Staten, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cleveland, Ohio, Verenigde Staten, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Verenigde Staten, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Verenigde Staten, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Verenigde Staten, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Verenigde Staten, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Verenigde Staten, 43228
- Doctors Hospital
-
Columbus, Ohio, Verenigde Staten, 43213
- Mount Carmel East Hospital
-
Columbus, Ohio, Verenigde Staten, 43215
- Grant Medical Center
-
Columbus, Ohio, Verenigde Staten, 43222
- Mount Carmel Health Center West
-
Dayton, Ohio, Verenigde Staten, 45409
- Miami Valley Hospital
-
Delaware, Ohio, Verenigde Staten, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Verenigde Staten, 43015
- Grady Memorial Hospital
-
Kettering, Ohio, Verenigde Staten, 45409
- Greater Dayton Cancer Center
-
Lancaster, Ohio, Verenigde Staten, 43130
- Fairfield Medical Center
-
Mansfield, Ohio, Verenigde Staten, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Mansfield, Ohio, Verenigde Staten, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, Verenigde Staten, 45750
- Marietta Memorial Hospital
-
Marion, Ohio, Verenigde Staten, 43302
- OhioHealth Marion General Hospital
-
Mayfield Heights, Ohio, Verenigde Staten, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Verenigde Staten, 43050
- Knox Community Hospital
-
Newark, Ohio, Verenigde Staten, 43055
- Licking Memorial Hospital
-
Portsmouth, Ohio, Verenigde Staten, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Verenigde Staten, 44870
- North Coast Cancer Care
-
Sylvania, Ohio, Verenigde Staten, 43560
- ProMedica Flower Hospital
-
Warrensville Heights, Ohio, Verenigde Staten, 44122
- South Pointe Hospital
-
West Chester, Ohio, Verenigde Staten, 45069
- University of Cincinnati Cancer Center-West Chester
-
Westerville, Ohio, Verenigde Staten, 43081
- Saint Ann's Hospital
-
Zanesville, Ohio, Verenigde Staten, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Lawton, Oklahoma, Verenigde Staten, 73505
- Cancer Centers of Southwest Oklahoma Research
-
Oklahoma City, Oklahoma, Verenigde Staten, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Verenigde Staten, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
Tulsa, Oklahoma, Verenigde Staten, 74133
- Cancer Treatment Centers of America
-
-
Oregon
-
Bend, Oregon, Verenigde Staten, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Verenigde Staten, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Verenigde Staten, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Verenigde Staten, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Verenigde Staten, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City, Oregon, Verenigde Staten, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Verenigde Staten, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Verenigde Staten, 97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Verenigde Staten, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Allentown, Pennsylvania, Verenigde Staten, 18104
- Saint Luke's Cancer Center - Allentown
-
Bethlehem, Pennsylvania, Verenigde Staten, 18017
- Lehigh Valley Hospital - Muhlenberg
-
Bethlehem, Pennsylvania, Verenigde Staten, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Easton, Pennsylvania, Verenigde Staten, 18045
- Saint Luke's Hospital-Anderson Campus
-
Erie, Pennsylvania, Verenigde Staten, 16544
- Saint Vincent Hospital
-
Harrisburg, Pennsylvania, Verenigde Staten, 17109
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus
-
Jefferson Hills, Pennsylvania, Verenigde Staten, 15025
- Jefferson Hospital
-
Monroeville, Pennsylvania, Verenigde Staten, 15146
- Forbes Hospital
-
Natrona Heights, Pennsylvania, Verenigde Staten, 15065
- Allegheny Valley Hospital
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15224
- West Penn Hospital
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15232
- UPMC Hillman Cancer Center
-
Quakertown, Pennsylvania, Verenigde Staten, 18951
- Saint Luke's Hospital-Quakertown Campus
-
West Reading, Pennsylvania, Verenigde Staten, 19611
- Reading Hospital
-
Wexford, Pennsylvania, Verenigde Staten, 15090
- Wexford Health and Wellness Pavilion
-
Willow Grove, Pennsylvania, Verenigde Staten, 19090
- Asplundh Cancer Pavilion
-
-
South Carolina
-
Anderson, South Carolina, Verenigde Staten, 29621
- AnMed Health Cancer Center
-
Beaufort, South Carolina, Verenigde Staten, 29902
- Beaufort Memorial Hospital
-
Boiling Springs, South Carolina, Verenigde Staten, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Verenigde Staten, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Verenigde Staten, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Verenigde Staten, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Verenigde Staten, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Verenigde Staten, 29605
- Prisma Health Cancer Institute - Butternut
-
Greenville, South Carolina, Verenigde Staten, 29601
- Saint Francis Hospital
-
Greer, South Carolina, Verenigde Staten, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Verenigde Staten, 29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg, South Carolina, Verenigde Staten, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Aberdeen, South Dakota, Verenigde Staten, 57401
- Avera Cancer Institute-Aberdeen
-
Sioux Falls, South Dakota, Verenigde Staten, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Verenigde Staten, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Verenigde Staten, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Bristol, Tennessee, Verenigde Staten, 37620
- Bristol Regional Medical Center
-
Collierville, Tennessee, Verenigde Staten, 38017
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Cookeville, Tennessee, Verenigde Staten, 38501
- Cookeville Regional Medical Center
-
Johnson City, Tennessee, Verenigde Staten, 37604
- Wellmont Medical Associates Oncology and Hematology-Johnson City
-
Kingsport, Tennessee, Verenigde Staten, 37660
- Ballad Health Cancer Care - Kingsport
-
Kingsport, Tennessee, Verenigde Staten, 37660
- Wellmont Holston Valley Hospital and Medical Center
-
Memphis, Tennessee, Verenigde Staten, 38120
- Baptist Memorial Hospital and Cancer Center-Memphis
-
-
Texas
-
Amarillo, Texas, Verenigde Staten, 79106
- The Don and Sybil Harrington Cancer Center
-
Beaumont, Texas, Verenigde Staten, 77701
- Baptist Hospitals of Southeast Texas Cancer Center
-
Conroe, Texas, Verenigde Staten, 77384
- UT MD Anderson - The Woodlands
-
Dallas, Texas, Verenigde Staten, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Verenigde Staten, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Edinburg, Texas, Verenigde Staten, 78539
- STCC at DHR Health Institute for Research and Development
-
Houston, Texas, Verenigde Staten, 77026-1967
- Lyndon Baines Johnson General Hospital
-
Houston, Texas, Verenigde Staten, 77030
- UT MD Anderson Cancer Center
-
Houston, Texas, Verenigde Staten, 77030
- Houston Methodist Hospital
-
Houston, Texas, Verenigde Staten, 77079
- UT MD Anderson - West Houston
-
League City, Texas, Verenigde Staten, 77573
- UT MD Anderson - League City
-
Port Arthur, Texas, Verenigde Staten, 77642
- Baptist Regional Cancer Network-Cancer Center of Southeast Texas
-
Sugar Land, Texas, Verenigde Staten, 77478
- UT MD Anderson - Sugar Land
-
Temple, Texas, Verenigde Staten, 76508
- Scott and White Memorial Hospital
-
-
Utah
-
Salt Lake City, Utah, Verenigde Staten, 84112
- Huntsman Cancer Institute/University of Utah
-
-
Vermont
-
Saint Johnsbury, Vermont, Verenigde Staten, 05819
- Dartmouth Cancer Center - North
-
-
Virginia
-
Bristol, Virginia, Verenigde Staten, 24201
- Ballad Health Cancer Care - Bristol
-
Burke, Virginia, Verenigde Staten, 22015
- Kaiser Permanente-Burke Medical Center
-
Fishersville, Virginia, Verenigde Staten, 22939
- Augusta Health Center for Cancer and Blood Disorders
-
Lynchburg, Virginia, Verenigde Staten, 24501
- Centra Alan B Pearson Regional Cancer Center
-
McLean, Virginia, Verenigde Staten, 22102
- Kaiser Permanente Tysons Corner Medical Center
-
Norton, Virginia, Verenigde Staten, 24273
- Ballad Health Cancer Care - Norton
-
Richmond, Virginia, Verenigde Staten, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Verenigde Staten, 23229
- Virginia Cancer Institute
-
Richmond, Virginia, Verenigde Staten, 23298
- VCU Massey Comprehensive Cancer Center
-
South Hill, Virginia, Verenigde Staten, 23970
- VCU Community Memorial Health Center
-
Woodbridge, Virginia, Verenigde Staten, 22192
- Kaiser Permanente-Caton Hill Medical Center
-
-
Washington
-
Edmonds, Washington, Verenigde Staten, 98026
- Swedish Cancer Institute-Edmonds
-
Issaquah, Washington, Verenigde Staten, 98029
- Swedish Cancer Institute-Issaquah
-
Port Townsend, Washington, Verenigde Staten, 98368
- Jefferson Healthcare
-
Seattle, Washington, Verenigde Staten, 98122
- Swedish Medical Center-First Hill
-
Spokane, Washington, Verenigde Staten, 99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane, Washington, Verenigde Staten, 99218
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
-
West Virginia
-
Charleston, West Virginia, Verenigde Staten, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
Morgantown, West Virginia, Verenigde Staten, 26506
- West Virginia University Healthcare
-
Parkersburg, West Virginia, Verenigde Staten, 26101
- Camden Clark Medical Center
-
-
Wisconsin
-
Antigo, Wisconsin, Verenigde Staten, 54409
- Aspirus Cancer Care-Antigo-Volm Cancer Center
-
Appleton, Wisconsin, Verenigde Staten, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, Verenigde Staten, 54915
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
-
Ashland, Wisconsin, Verenigde Staten, 54806
- Duluth Clinic Ashland
-
Brookfield, Wisconsin, Verenigde Staten, 53045
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
-
Eau Claire, Wisconsin, Verenigde Staten, 54701
- Marshfield Medical Center-EC Cancer Center
-
Franklin, Wisconsin, Verenigde Staten, 53132
- Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
-
Green Bay, Wisconsin, Verenigde Staten, 54301
- Bellin Memorial Hospital
-
Janesville, Wisconsin, Verenigde Staten, 53548
- Mercyhealth Hospital and Cancer Center - Janesville
-
Johnson Creek, Wisconsin, Verenigde Staten, 53038
- University of Wisconsin Carbone Cancer Center - Johnson Creek
-
La Crosse, Wisconsin, Verenigde Staten, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Verenigde Staten, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Madison, Wisconsin, Verenigde Staten, 53718
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Marshfield, Wisconsin, Verenigde Staten, 54449
- Marshfield Medical Center-Marshfield
-
Medford, Wisconsin, Verenigde Staten, 54451
- Aspirus Medford Hospital
-
Minocqua, Wisconsin, Verenigde Staten, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Verenigde Staten, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Verenigde Staten, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Verenigde Staten, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, Verenigde Staten, 54904
- Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
-
Racine, Wisconsin, Verenigde Staten, 53405
- Ascension All Saints Hospital-Spring Street-Racine
-
Rhinelander, Wisconsin, Verenigde Staten, 54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake, Wisconsin, Verenigde Staten, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Verenigde Staten, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Waukesha, Wisconsin, Verenigde Staten, 53188
- UW Cancer Center at ProHealth Care
-
Waukesha, Wisconsin, Verenigde Staten, 53188
- ProHealth Waukesha Memorial Hospital
-
Wausau, Wisconsin, Verenigde Staten, 54401
- Aspirus Cancer Care-Wausau
-
Wauwatosa, Wisconsin, Verenigde Staten, 53226
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
-
Weston, Wisconsin, Verenigde Staten, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Verenigde Staten, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Wyoming
-
Cheyenne, Wyoming, Verenigde Staten, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, Verenigde Staten, 82414
- Billings Clinic-Cody
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
-
Age >= 18 years
-
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2
-
Diagnosis of metastatic adenocarcinoma of colon or rectum without previous chemotherapy or any other systemic therapy for metastatic colorectal cancer except for one cycle of FOLFOX or capecitabine and oxaliplatin (CAPOX), either with or without bevacizumab prior to enrollment. Upon enrollment, the preceding single cycle of FOLFOX or FOLFOX + bevacizumab, if the patient received one, will not count towards patients' assessments per protocol. Cycle 1 day 1 (C1D1) of atezolizumab or C1D1 of mFOLFOX6/bevacizumab + atezolizumab will correspond to the first day the patient received therapy on trial
-
Tumor determined to be mismatch-repair deficient (dMMR) by Clinical Laboratory Improvement Act (CLIA)-certified immunohistochemical (IHC) assay with a panel of all four IHC markers, including MLH1, MSH2, PMS2, and MSH6; alternatively, MSI-H diagnosed by polymerase chain reaction (PCR)-based assessment of microsatellite alterations (either Bethesda markers or Pentaplex panel) or by next-generation sequencing (NGS) are eligible
-
Documentation by PET/CT scan, CT scan, or MRI that the patient has measurable metastatic disease per RECIST 1.1
-
No immediate need for surgical intervention for the primary tumor or palliative diversion/bypass
-
Absolute neutrophil count (ANC) must be >= 1500/mm^3 (obtained within 28 days prior randomization)
-
Platelet count must be >= 100,000/mm^3 (obtained within 28 days prior randomization)
-
Hemoglobin must be >= 8 g/dL (obtained within 28 days prior randomization)
-
Total bilirubin must be =< 4 x ULN (upper limit of normal) (obtained within 28 days prior randomization); and
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) must be =< 3 x ULN for the lab with the following exception: for patients with documented liver metastases, AST and ALT must be =< 5 x ULN (obtained within 28 days prior randomization)
-
Calculated creatinine clearance >= 30 mL/min (obtained within 28 days prior randomization)
-
A urine sample tested for proteinuria by either the dipstick method, urinalysis (UA), or a urine protein creatinine (UPC) ratio:
- The dipstick method must indicate 0-1+ protein; if dipstick reading is >= 2+, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
- A urine protein creatinine (UPC) ratio must be < 1.0; if the UPC ratio is >= 1.0 a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours
- Urinalysis must indicate < 30 mg/dl. If urinalysis >= 30 mg/dl, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
-
International normalized ratio of prothrombin time (INR) and prothrombin time (PT) must be =< 1.5 x ULN for the lab within 28 days before randomization; patients who are therapeutically treated with an agent such as warfarin may participate if they are on a stable dose and no underlying abnormality in coagulation parameters exists per medical history, regardless of PT/INR results
-
Pregnancy test done within 28 days prior randomization must be negative (for women of childbearing potential only); pregnancy testing should be performed according to institutional standards; administration of atezolizumab or mFOLFOX6/bevacizumab/atezolizumab may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately
-
Women of child-bearing potential and men must agree to use adequate contraception methods that result in a failure rate of < 1% per year during the treatment period (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 5 months (150 days) after the last dose of atezolizumab, 6 months after the last dose of bevacizumab, and 6 months after the last dose of mFOLFOX6; a woman is considered to be of childbearing potential if she is not postmenopausal, has not reached a postmenopausal state (>= 12 continuous months of amenorrhea with no identified cause other than menopause), and has not undergone surgical sterilization (removal of ovaries and/or uterus); examples of contraceptive methods with a failure rate of < 1% per year include: bilateral tubal ligation; male partner sterilization; intrauterine devices; the reliability of sexual abstinence should be evaluated in relation to the duration of the clinical study and the preferred and usual lifestyle of the patient; periodic abstinence (e.g., calendar, ovulation, symptothermal, or postovulation methods) and withdrawal are not acceptable methods of contraception; men must refrain from donating sperm during this same period
Exclusion Criteria:
-
Known hypersensitivity to Chinese hamster ovary cell products or other recombinant human antibodies, fluoropyrimidines, folic acid derivatives or oxaliplatin
-
Uncontrolled high blood pressure defined as systolic blood pressure (BP) > 150 mmHg or diastolic BP > 100 mmHg with or without anti-hypertensive medication; patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria
-
Documented New York Heart Association (NYHA) class III or IV congestive heart failure
-
Serious or non-healing wound, skin ulcer, or bone fracture
-
History of inherited bleeding diathesis, gastrointestinal (GI) perforation, significant vascular disease (e.g., aortic aneurysm requiring surgical repair or recent arterial thrombosis or symptomatic peripheral ischemia, transient ischemic attack [TIA], cerebrovascular accident [CVA] or arterial thrombotic event), abdominal fistula, intra-abdominal abscess, or active GI bleeding (with cause not addressed) within 6 months prior to randomization, or other medical condition in the opinion of the treating oncologist that makes the risk of cardiovascular or bleeding complications with bevacizumab use unacceptably high
-
Other malignancies are excluded unless the patient has completed therapy for the malignancy >= 12 months prior to randomization and is considered disease-free; patients with the following cancers are eligible if diagnosed and treated within the past 12 months: in situ carcinomas or basal cell and squamous cell carcinoma of the skin
-
Known DPD (dihydro pyrimidine dehydrogenase) deficiency
-
Symptomatic peripheral sensory neuropathy >= grade 2 (Common Terminology Criteria for Adverse Events [CTCAE] version [v] 5.0)
-
Prior treatment with oxaliplatin chemotherapy within 6 months prior to randomization
-
History of grade 2 hemoptysis (defined as 2.5 mL of bright red blood per episode) within 1 month prior to screening
-
Prior treatment with anti-PD-1, or anti-PD-L1 therapeutic antibody or pathway-targeting agents; patients who have received prior treatment with anti-CTLA-4 may be enrolled provided the following requirements are met:
- Minimum of 12 weeks from the first dose of anti-CTLA-4 and > 6 weeks from the last dose to randomization
- No history of severe immune-related adverse effects (CTCAE grade 3 and 4) from anti-CTLA-4
-
Treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 14 days prior to randomization; however,
- Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one-time dose of dexamethasone for nausea; or chronic daily treatment with corticosteroids with a dose of =< 10 mg/day methylprednisolone equivalent) may be enrolled
- The use of inhaled corticosteroids and mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed
-
Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease; however,
- Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HbsAg] test and a positive anti-HBc [antibody to hepatitis B core antigen] antibody test) are eligible if polymerase chain reaction (PCR) for hepatits B virus (HBV) ribonucleic acid (RNA) is negative per local guidelines
- Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction (PCR) is negative for HCV RNA per local guidelines
-
History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis; however,
-
Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible
-
Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible
-
Patients with eczema, psoriasis, lichen simplex chronicus or vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis would be excluded) are permitted provided that they meet the following conditions:
- Patients with psoriasis must have a baseline ophthalmologic exam to rule out ocular manifestations
- Rash must cover less than 10% of body surface area (BSA)
- Disease is well controlled at baseline and only requiring low potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, fluocinolone 0.01%, desonide 0.05%, alclometasone dipropionate 0.05%)
- No acute exacerbations of underlying condition within the last 12 months (not requiring psoralen plus ultraviolet A radiation [PUVA], methotrexate, retinoids, biologic agents, oral calcineurin inhibitors; high potency or oral steroids)
-
-
History of idiopathic pulmonary fibrosis, organizing pneumonia (i.e., bronchiolitis obliterans, cryptogenic organizing pneumonia, etc.), or active or recently active (within 90 days of randomization) pneumonitis (including drug induced) that required systemic immunosuppressive therapy (i.e. corticosteroids, etc.). History of radiation pneumonitis in the radiation field (fibrosis) is permitted
-
History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins
-
Patients with known active tuberculosis (TB) are excluded
-
Severe infections within 28 days prior to randomization, including but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia
-
Signs or symptoms of infection within 14 days prior to randomization
-
Received oral or intravenous (IV) antibiotics within 14 days prior to randomization; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
-
Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to randomization or anticipation of need for a major surgical procedure during the course of the study
-
The administration of a live, attenuated vaccine within 28 days prior to randomization
-
Pregnant women are excluded from this study because atezolizumab is an agent with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding should be discontinued if the mother is treated with atezolizumab; these potential risks may also apply to other agents used in this study; (Note: pregnancy testing should be performed within 28 days prior to randomization according to institutional standards for women of childbearing potential)
-
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial
-
Patients with prior allogeneic bone marrow transplantation or prior solid organ transplantation
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Arm I (bevacizumab, mFOLFOX6)
Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. (CLOSED TO ACCRUAL) |
Ancillary studies
Andere namen:
Given IV
Andere namen:
Given IV
Andere namen:
Undergo MRI
Andere namen:
Ancillary studies Undergo collection of blood samples
Andere namen:
Given IV
Andere namen:
Undergo CT or CT/PET
Andere namen:
Given IV
Andere namen:
Undergo CT/PET
Andere namen:
|
|
Experimenteel: Arm II (atezolizumab)
Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. |
Ancillary studies
Andere namen:
Undergo MRI
Andere namen:
Ancillary studies Undergo collection of blood samples
Andere namen:
Given IV
Andere namen:
Undergo CT or CT/PET
Andere namen:
Undergo CT/PET
Andere namen:
|
|
Experimenteel: Arm III (atezolizumab, bevacizumab, mFOLFOX6)
Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. |
Ancillary studies
Andere namen:
Given IV
Andere namen:
Given IV
Andere namen:
Undergo MRI
Andere namen:
Ancillary studies Undergo collection of blood samples
Andere namen:
Given IV
Andere namen:
Given IV
Andere namen:
Undergo CT or CT/PET
Andere namen:
Given IV
Andere namen:
Undergo CT/PET
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Progression free survival (PFS)
Tijdsspanne: From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years
|
The analysis set is intent-to-treat (ITT). The experimental arms will be compared to the control arm by the log-rank test stratified by BRAF status (V600E mutation or not), metastatic disease: (liver-only, extra-hepatic), and prior adjuvant therapy for colon cancer (yes, no). Hazard ratios and associated confidence intervals from a stratified Cox regression model will also be reported along with estimates of the distributions of time to PFS event by the method of Kaplan and Meier. Sensitivity analyses accounting for 2 or more consecutively missed scheduled tumor imaging scans before progression/death will also be conducted. |
From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Tarief van PFS
Tijdsspanne: Op 12 maanden
|
Op 12 maanden
|
|
|
Overall survival (OS)
Tijdsspanne: The time from randomization to death from any cause, assessed up to 5 years
|
Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals. |
The time from randomization to death from any cause, assessed up to 5 years
|
|
Objective response rate (ORR) (complete response [CR] or partial response [PR])
Tijdsspanne: Up to 5 years
|
Assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemotherapy [chemo]) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment. |
Up to 5 years
|
|
Incidence of adverse events
Tijdsspanne: Up to 30 days after last cycle
|
Defined by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The safety profile will be described by tabulating the maximum observed grade of adverse event for each individual adverse event, for each system organ class, and overall using the Safety population. |
Up to 30 days after last cycle
|
|
Disease control rate (CR + PR + stable disease [SD])
Tijdsspanne: At 12 months
|
Assessed by RECIST 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemo) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment. |
At 12 months
|
|
Duration of overall response (CR or PR)
Tijdsspanne: From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years
|
Assessed by RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals. |
From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years
|
|
Duration of SD
Tijdsspanne: From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years
|
Assessed per RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals. |
From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Severity of fatigue
Tijdsspanne: At 16 weeks
|
Will use the ITT population. Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue questionnaire. Will be compared between the control arm (Chemo-bevacizumab [Bev]) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered. |
At 16 weeks
|
|
Physical functioning
Tijdsspanne: At 16 weeks
|
Will use the ITT population. Measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire (QLQ)-C30 physical functioning scale. Will be compared between the control arm (Chemo-Bev) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered. |
At 16 weeks
|
|
Health utility scores
Tijdsspanne: Up to 5 years
|
Will use the ITT population. Will be measured using the EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) questionnaire. |
Up to 5 years
|
|
Proportion of patients reporting each response option at each assessment timepoint by treatment arm for item GP5 from the Functional Assessment of Cancer Therapy - General (FACT-G)
Tijdsspanne: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Intratumoral lymphocyte PD-L1+ expression (>= 1 % is positive) by immunohistochemistry (IHC) as a predictive biomarker of efficacy
Tijdsspanne: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Efficacy dependent on the number of somatic mutations
Tijdsspanne: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Efficacy in tumors with MLH1 silencing
Tijdsspanne: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Change in quantification of cell free deoxyribonucleic acid (cfDNA) mutations
Tijdsspanne: Baseline up to 5 years
|
Will use the ITT population. |
Baseline up to 5 years
|
|
Development of progression or relapse to treatment in cfDNA
Tijdsspanne: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Changes in T-cell repertoire diversity as a predictive biomarker of efficacy
Tijdsspanne: Baseline up to 5 years
|
Will use the ITT population. |
Baseline up to 5 years
|
|
PFS of patients with high levels of diversity
Tijdsspanne: Up to 5 years
|
Compared to patients with low levels of diversity. Will use the ITT population. |
Up to 5 years
|
|
Change in T-cell diversity
Tijdsspanne: Baseline to first restaging between immunotherapy arms and the standard of care arm
|
Will use the ITT population. |
Baseline to first restaging between immunotherapy arms and the standard of care arm
|
|
Mechanism of immune resistance to PD-1 blockade in mismatch repair deficient (dMMR)/microsatellite instability-high metastatic colorectal cancer (mCRC) by comparative analysis of tumor samples collected
Tijdsspanne: Baseline up to 5 years
|
Will use the ITT population. |
Baseline up to 5 years
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Caio Max S Rocha Lima, NRG Oncology
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Geschat)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Neoplasmata per site
- Neoplasmata
- Darmziekten
- Gastro-intestinale neoplasmata
- Neoplasmata van het spijsverteringsstelsel
- Ziekten van het spijsverteringsstelsel
- Gastro-intestinale aandoeningen
- Intestinale neoplasmata
- Rectale ziekten
- Colon Ziekten
- Colorectale neoplasmata
- Aminozuren, peptiden en eiwitten
- Eiwitten
- Zwavelverbindingen
- Organische chemicaliën
- Heterocyclische verbindingen, 1-ring
- Heterocyclische verbindingen
- Heterocyclische verbindingen, 2-ring
- Heterocyclische verbindingen, gefuseerd ring
- Onderzoekstechnieken
- Klinische laboratoriumtechnieken
- Diagnostische technieken en procedures
- Diagnose
- Enzymen en co -enzymen
- Antilichamen, monoklonaal, gehumaniseerd
- Antilichamen, monoklonaal
- Antilichamen
- Immunoglobulinen
- Immunoproteïnen
- Bloedeiwitten
- Serum -globulines
- Globulines
- Anorganische chemicaliën
- Coördinatiecomplexen
- Pyrimidines
- Chemie -technieken, analytisch
- Spectrumanalyse
- Formyltetrahydrofolates
- Tetrahydrofolaten
- Foliumzuur
- Pterins
- Pteridines
- Uracil
- Pyrimidinonen
- Co -enzymen
- Immunoglobuline -isotypes
- Sulfiden
- Anionen
- Ionen
- Elektrolyten
- Waterstofsulfide
- Oxaliplatine
- Bevacizumab
- Fluorouracil
- Leucovorin
- Immunoglobuline G
- Exemplaarbehandeling
- Magnetische resonantiespectroscopie
- Disulfides
- atezolizumab
- Dehydroforafur
Andere studie-ID-nummers
- NCI-2016-01961
- U10CA180868 (Subsidie/contract van de Amerikaanse NIH)
- NCI-2016-01961 (Register-ID: CTRP (Clinical Trial Reporting Program))
- NRG-GI004/S1610
- NRG-GI004 (Andere identificatie: CTEP)
- NRG-GI004 (Andere identificatie: NRG Oncology)
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .